Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Population Health Investment Co., Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| MAVERICK CAPITAL LTD reports a 0% stake in Population Health Investment Co., Inc. |
| 01/30/2023 |
SC 13G/A
| MILLENNIUM MANAGEMENT LLC reports a 0% stake in POPULATION HEALTH INVESTMENT CO., INC. |
| 12/12/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 11/29/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 11/18/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/12/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/22/2022 |
SC 13G
| MILLENNIUM MANAGEMENT LLC reports a 5.3% stake in POPULATION HEALTH INVESTMENT CO., INC. |
| 03/30/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 02/14/2022 |
SC 13G
| LEVIN CAPITAL STRATEGIES, L.P. reports a 10.5% stake in POPULATION HEALTH INVESTMENT CO., INC. |
| 02/14/2022 |
SC 13G/A
| MAVERICK CAPITAL LTD reports a 6.9% stake in Population Health Investment Co., Inc. |
| 02/14/2022 |
SC 13G/A
| GLAZER CAPITAL, LLC reports a 1.4% stake in Population Health Investment Co Inc |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2022 |
SC 13G
| Sculptor Capital LP reports a 5.7% stake in POPULATION HEALTH INVESTMENT CO., INC. |
| 01/07/2022 |
10-Q/A
| Quarterly Report for the period ended September 30, 2021 [amend] |
| 01/07/2022 |
10-K/A
| Annual Report for the period ended December 31, 2020 [amend] |
| 12/22/2021 |
8-K
| Quarterly results |
| 11/12/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 08/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 05/24/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 05/19/2021 |
10-K/A
| Annual Report for the period ended December 31, 2020 [amend] |
| 05/17/2021 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 05/13/2021 |
8-K
| Quarterly results |
| 03/31/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 02/16/2021 |
SC 13G
| MAVERICK CAPITAL LTD reports a 6.9% stake in Population Health Investment Co., Inc. |
| 01/28/2021 |
4
| Population Health Investment Holding, Inc. (10% Owner) has filed a Form 4 on Population Health Investment Co., Inc.|
Txns:
| Disposed of 258,750 options to buy
@ $1500, valued at
$388.1M
|
|
| 01/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| Futch Clarke (Director) has filed a Form 4 on Population Health Investment Co., Inc.|
Txns:
| Acquired 43,125 options to buy
@ $250, valued at
$10.8M
|
|
| 01/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
8-K
| Quarterly results |
| 11/27/2020 |
8-K
| Other Events, Financial Statements and Exhibits |
| 11/25/2020 |
SC 13G
| Foresite Capital Fund V, L.P. reports a 7% stake in Population Health Investment Co., Inc. |
| 11/20/2020 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : November 16, 2020 Population Health Investment Co., Inc. Cayman Islands 001-39706 98-1556837 One World Financial Center New York, New York 10281 Registrant's telephone number, including area code: 993-3113 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the...",
"Underwriting Agreement, by and among the Company and J.P. Morgan Securities LLC as representatives of the underwriters",
"Amended and Restated Memorandum and Articles of Association",
"Warrant Agreement, between the Company and Continental Stock Transfer & Trust Company",
"Investment Management Trust Agreement, between the Company and Continental Stock Transfer & Trust Company",
"Registration and Shareholder Rights Agreement, by and among the Company and the Sponsor",
"Private Placement Warrants Purchase Agreement, between the Company and the Sponsor",
"Letter Agreement, by and among the Company, the Sponsor and each director and officer of the Company",
"Population Health Announces Pricing Of $150 Million Initial Public Offering NEW YORK, Nov. 18, 2020 /PRNewswire/ — Population Health Investment Co., Inc. announced today the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Capital Market and trade under the ticker symbol “PHICU” beginning on November 18, 2020. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at $11.50 per share. After the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “PHIC” and “PHICW,” respectively. The offering is expected to..." |
|
|
|
|